Computer aided drug design, its success and limitation
dc.contributor.author | Ansari, Nikhat | |
dc.contributor.author | Bengal, Gajanan Bhujangrao (17PH05) | |
dc.contributor.author | Dabir, Safa Rafique (17PH07) | |
dc.contributor.author | KArbari, Tuba Salim (17PH16) | |
dc.contributor.author | Sayyed, Gufran Ali Meer Ajagar Ali (17PH42) | |
dc.date.accessioned | 2021-11-12T05:40:09Z | |
dc.date.available | 2021-11-12T05:40:09Z | |
dc.date.issued | 2020-05 | |
dc.description.abstract | Moderndrugdiscoveryischaracterizedbytheproductionofvastquantitiesofcompoundsand theneedtoexaminethesehugelibrariesinshortperiodsoftime Theneedtostore,manageandanalyzetheserapidlyincreasingresourceshasgivenrisetothe fieldknownascomputer-aideddrugdesign(CADD). CADDrepresentscomputationalmethodsandresourcesthatareusedtofacilitatethedesign anddiscoveryofnewtherapeuticsolutions. Digitalrepositories,containingdetailedinformationondrugsandotherusefulcompounds,are goldminesfortheStudyofchemicalreactionscapabilities.Designlibraries,withthepotentialto generatemolecularvariantsintheirentirety,allowtheselectionandsamplingofchemical compoundswithdiversecharacteristics. Structure-baseddrugdesignandligand-baseddrugdesign aretwomethodscommonlyusedincomputer-aideddrugdesign.Inthisarticle,wediscussthe theorybehindbothmethods,aswellas theirsuccessfulapplicationsandlimitations. | en_US |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/3685 | |
dc.language.iso | en | en_US |
dc.publisher | AIKTC | en_US |
dc.subject | Project Report - SoP | en_US |
dc.title | Computer aided drug design, its success and limitation | en_US |
dc.type | Project Report | en_US |